Science & Technology
Medical Center plays key role in new Huntington’s drug
Medical Center researchers were instrumental in the U.S. Food and Drug Administration’s recent approval of SD-809 (deutetrabenazine) to treat Huntington’s disease.
Medical Center researchers were instrumental in the U.S. Food and Drug Administration’s recent approval of SD-809 (deutetrabenazine) to treat Huntington’s disease.